Dr. Toppmeyer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
195 Little Albany St
New Brunswick, NJ 08901Phone+1 732-235-2465Fax+1 732-212-0713
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1994
Albany Medical CollegeClass of 1985
Certifications & Licensure
NJ State Medical License 1995 - 2025
PA State Medical License 1986 - 1990- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients Start of enrollment: 2018 Jan 29
Publications & Presentations
PubMed
- 1318 citationsAdjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerJoseph A. Sparano, Robert Gray, Della F. Makower, Kathleen I. Pritchard, Kathy S. Albain
The New England Journal of Medicine. 2018-06-03 - 69 citationsRace, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S. Albain, Robert Gray, Della F. Makower, Amir Faghih, Daniel F. Hayes
Journal of the National Cancer Institute. 2021-04-06 - 412 citationsPembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 studySylvia Adams, Sherene Loi, Deborah Toppmeyer, David W. Cescon, M. De Laurentiis
Annals of Oncology. 2019-03-01
Press Mentions
New Chief of Thoracic & Head & Neck Medical Oncology NamedSeptember 1st, 2021- Salacz Named Director of Neuro-Oncology at Rutgers Cancer Institute of N.JMarch 25th, 2021
- New Director of Neuro-Oncology Named to Rutgers Cancer InstMarch 24th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
